Purified anti-RNA Polymerase II RPB1 Antibody

Pricing & Availability
Clone
H5 (See other available formats)
Regulatory Status
RUO
Other Names
DNA-directed RNA polymerase II subunit RPB1, RNA polymerase II subunit B1, DNA-directed RNA polymerase II subunit A, RNA-directed RNA polymerase II subunit RPB1, DNA-directed RNA polymerase III largest subunit
Isotype
Mouse IgM, κ
Ave. Rating
Submit a Review
Product Citations
publications
H5_PURE_RNAPolymeraseII_Antibody_1_WB_060418
Total lysates (15 µg protein) from HeLa, Daudi (Human), Raw264.7 (Mouse) and UMR106 (Rat) were resolved by electrophoresis (4-12% Bis-Tris gel), transferred to nitrocellulose, and probed with 1:500 (1 µg/ml) purified anti-RNA polymerase II antibody, clone H5. Proteins were visualized using chemiluminescence detection by incubation with and HRP Goat anti-Mouse secondary antibody (Cat. No. 405306, 1:3000 dilution). Direct-Blot™ HRP anti-β-actin antibody was used as a loading control (Cat. No. 664804, 1:25,000 dilution).
  • H5_PURE_RNAPolymeraseII_Antibody_1_WB_060418
    Total lysates (15 µg protein) from HeLa, Daudi (Human), Raw264.7 (Mouse) and UMR106 (Rat) were resolved by electrophoresis (4-12% Bis-Tris gel), transferred to nitrocellulose, and probed with 1:500 (1 µg/ml) purified anti-RNA polymerase II antibody, clone H5. Proteins were visualized using chemiluminescence detection by incubation with and HRP Goat anti-Mouse secondary antibody (Cat. No. 405306, 1:3000 dilution). Direct-Blot™ HRP anti-β-actin antibody was used as a loading control (Cat. No. 664804, 1:25,000 dilution).
  • H5_PURE_RNAPolymeraseII_Antibody_2_IF_031516
    HeLa cells were fixed with 2% paraformaldehyde (PFA) then permeabilized with 0.5% Triton X-100 for five minutes. The cells were then blocked with 5% FBS in PBS for one hour at room temperature followed by incubation with anti-RNA Polymerase II RPB1 (clone H5) antibody at 4 µg/ml for 24 hours at 4°C. Following primary antibody incubation, the cells were incubated with Alexa Fluor® 488 conjugated goat anti-mouse IgM secondary antibody and counterstained with DAPI.
Cat # Size Price Save
920203 25 µg ¥19,580
920204 100 µg ¥55,660
Description

RPB1 is the catalytic and largest component of RNA polymerase II, which synthesizes mRNA precursors and many functional non-coding RNAs. It forms the polymerase active center together with RPB2, the second largest subunit. Polymerase II (Pol II) is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relatively to each other. RPB1 is part of the core element with the central large cleft, the clamp element that moves to open and close the cleft, and the jaws that are thought to grab the incoming DNA template. At the start of transcription, a single DNA template strand of the promoter is positioned within the central active site cleft of Pol II. Then, a bridging helix emanates from RPB1 and crosses the cleft near the catalytic site, which acts as a ratchet that moves the RNA-DNA hybrid through the active site by switching from straight to bent conformations during each nucleotide addition. This promotes translocation of Pol II. Pol II moves on the template during transcription elongation. Elongation is influenced by the phosphorylation status of the C-terminal domain (CTD) of Pol II's largest subunit (RPB1), which serves as a platform for assembling factors that regulate transcription initiation, elongation, termination, and mRNA processing. It can act as a RNA-dependent RNA polymerase when associated with small delta antigen of Hepatitis delta virus, being able to conform as both a replicate and transcriptase for the viral RNA circular genome.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Human, Rat
Reported Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
The antibody H5 was developed against a purified phosphorylated form of RNA polymerase II extracted from a transformed cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

WB - Quality tested
ICC - Verified
IP - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by Western blotting. For Western blotting, the suggested use of this reagent is 1.0 - 10.0 µg/ml. For Western blotting, the use of casein or BSA in the blocking solution rather than non-fat-dry milk is recommended. For immunofluorescence microscopy, a concentration range of 1.0 - 5.0 μg/ml is recommended. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation2,3.

The clone H5 was developed against a purified phosphorylated form of RNA polymerase II extracted from a transformed cell line. Pol II has two physiologically important phosphorylation sites: ser-2 and ser-5. Both sites are found in the heptapeptide repeat YSPTSPS at the C-terminal domain. Clone H5 recognizes the phosphoserine 2 (ser-2) of Pol II. Clone H5 is useful for immunofluorescence and Western blotting.

This clone is not recommended for ChIP (Chromatin Immunoprecipitation) assays (as determined by in-house testing).

This product weakly reacts with Mouse.

Application References

(PubMed link indicates BioLegend citation)
  1. Brown JM, et al. 2008. J. Cell. Biol. 182:1083. (WB, IF)
  2. Bregman DB, et al. 1995. Cell Biol. 129:287-98. (IP)
  3. Ahn SH, et al. 2004. Mol. Cell. 13:67. (IP)
  4. Pellizzoni L, et al. 2001. Cell Biol. 152(1):75. (IF)
  5. Patturajan M, et al. 1998. J. Biol. Chem. 273(8):4689. (WB)
Product Citations
  1. Andrs M, et al. 2023. Nat Commun. 14:1791. PubMed
  2. Oqani R, et al. 2016. PLoS One. 11: 0152254. PubMed
  3. Fitzwalter BE, et al. 2018. Dev Cell. 44:555. PubMed
  4. Butler AM, et al. 2018. Development. 145:. PubMed
  5. Wong MM et al. 2018. Developmental cell. 46(3):302-315 . PubMed
  6. Yurko N, et al. 2017. Mol Cell. 68:913. PubMed
  7. Li Y et al. 2017. Development (Cambridge, England). 144(18):3232-3240 . PubMed
  8. Montinaro A, et al. 2021. Cell Death Differ. Online ahead of print. PubMed
  9. Yamashita T, et al. 2017. Sci Rep. 7:39994. PubMed
  10. Ryu HY, et al. 2019. EMBO J. 38:e102003. PubMed
  11. Baluapuri A, et al. 2019. Mol Cell. 74:674. PubMed
  12. Kuhn TM, et al. 2019. J Cell Biol. 218:2945. PubMed
  13. Zhou KI, et al. 2019. Mol Cell. 76:70. PubMed
  14. Tolza C, et al. 2019. Mol Cancer Res. 17:1999. PubMed
  15. Rona G et al. 2018. eLife. 7 pii: e38771. PubMed
  16. Chappidi N, et al. 2020. Molecular Cell. 77(3):528-541.e8.. PubMed
  17. Zhang H et al. 2018. Cell. 175(5):1244-1258 . PubMed
  18. Stanek TJ, et al. 2021. EMBO J. 40:e102509. PubMed
  19. Pancholi A, et al. 2021. Mol Syst Biol. 17:e10272. PubMed
RRID
AB_2616695 (BioLegend Cat. No. 920203)
AB_2616695 (BioLegend Cat. No. 920204)

Antigen Details

Structure
RPB1 contains a C-terminus composed of heptapeptide repeats that are essential for polymerase activity. These repeats contain Ser and Thr residues that are phosphorylated in actively transcribing RNA polymerase. The predicted molecular weight is 220 kD.
Distribution

Nucleus and cytosol.

Function
RPB1 is the largest subunit of RNA polymerase II, the polymerase responsible for synthesizing messenger RNA in eukaryotes.
Biology Area
Cell Biology, Cell Cycle/DNA Replication
Gene ID
5430 View all products for this Gene ID
UniProt
View information about RNA Polymerase II on UniProt.org
Go To Top Version: 4    Revision Date: 12/21/2021

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account